These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8008080)

  • 1. Screening for human immunodeficiency virus in physicians. Who should we test and what will it cost.
    Levine AA; Sandler RS
    N C Med J; 1994 Apr; 55(4):136-40. PubMed ID: 8008080
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analysis of screening health care workers for HIV.
    Chavey WE; Cantor SB; Clover RD; Reinarz JA; Spann SJ
    J Fam Pract; 1994 Mar; 38(3):249-57. PubMed ID: 8126405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
    Doyle NM; Levison JE; Gardner MO
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to prenatal HIV testing.
    Remis RS; Patrick DM
    CMAJ; 1998 Jun; 158(11):1469-70. PubMed ID: 9629111
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential cost of screening surgeons for HIV.
    Roizen MF; Foss J; Mantha S
    JAMA; 1994 Aug; 272(6):434-5. PubMed ID: 8040976
    [No Abstract]   [Full Text] [Related]  

  • 6. Who should be screened for HIV infection? A cost-effectiveness analysis.
    McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
    Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening women of childbearing age for human immunodeficiency virus. A cost-benefit analysis.
    Brandeau ML; Owens DK; Sox CH; Wachter RM
    Arch Intern Med; 1992 Nov; 152(11):2229-37. PubMed ID: 1444682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV screening for healthcare providers: can we provide sense and sensibility without pride or prejudice?
    Henderson DK
    Infect Control Hosp Epidemiol; 1994 Oct; 15(10):631-4. PubMed ID: 7844333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk of transmission of HIV by blood products].
    Gürtler L
    Infusionsther Transfusionsmed; 1994 Oct; 21(5):295-6. PubMed ID: 7803990
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis sparks new debate about current HIV screening recommendations.
    Dis Manag Advis; 2007 Aug; 13(8):95-6, 85. PubMed ID: 17802675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mandatory screening for physicians performing seriously invasive procedures: an ethical analysis.
    Wiseman F
    Plast Surg Nurs; 1999; 19(3):167-70. PubMed ID: 10765305
    [No Abstract]   [Full Text] [Related]  

  • 12. [HIV test before ENT operations].
    Weidauer H
    HNO; 1994 Feb; 42(2):81. PubMed ID: 8163398
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost of HIV testing in the U.S. Army.
    Brown AE; Burke DS
    N Engl J Med; 1995 Apr; 332(14):963. PubMed ID: 7877666
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
    Gómez M
    Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening for HIV.
    Taiwo BO
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15901873
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of cost-effectiveness analysis in assessing HIV-prevention interventions.
    Kahn JG; Sanstad KC
    AIDS Public Policy J; 1997; 12(1):21-30. PubMed ID: 10915254
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost-effectiveness of HIV testing of physicians and dentists in the United States.
    Phillips KA; Lowe RA; Kahn JG; Lurie P; Avins AL; Ciccarone D
    JAMA; 1994 Mar; 271(11):851-8. PubMed ID: 8114240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic evaluation of mandatory premarital testing for HIV.
    McKay NL; Phillips KM
    Inquiry; 1991; 28(3):236-48. PubMed ID: 1833334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium: Job restrictions and disclosure requirements for HIV-infected health care professionals: whose privacy is it anyway?
    Closen ML; Elovitz ME; Leonard AS; Meyer KC; Spritz N
    NY Law Sch Law Rev; 1996; 41(1):5-56. PubMed ID: 12718306
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.